With sotrovimab in the balance, Biogen vet reunites with George Scangos at Vir; First woman to chair PhRMA has more in store at Takeda

Vir Biotechnology is getting another Biogen vet to join up as the startup’s new global CBO and EVP.

While Johanna Friedl-Naderer officially doesn’t start her first C-suite role for another few weeks on March 2, she will join the company in the midst of conflicting data regarding its GlaxoSmithKline-partnered Covid-19 antibody, and armed with decades of working at the recently-embroiled Biogen.